Fairmount Funds Management as of Dec. 31, 2019
Portfolio Holdings for Fairmount Funds Management
Fairmount Funds Management holds 15 positions in its portfolio as reported in the December 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Zogenix | 14.8 | $24M | 467k | 52.13 | |
| Insmed (INSM) | 14.3 | $24M | 989k | 23.88 | |
| ACADIA Pharmaceuticals (ACAD) | 13.4 | $22M | 516k | 42.78 | |
| Amarin Corporation (AMRN) | 10.9 | $18M | 842k | 21.44 | |
| Iovance Biotherapeutics (IOVA) | 7.6 | $13M | 454k | 27.68 | |
| Argenx Se (ARGX) | 7.6 | $13M | 78k | 160.52 | |
| Allakos (ALLK) | 7.4 | $12M | 129k | 95.36 | |
| Enanta Pharmaceuticals (ENTA) | 6.1 | $10M | 162k | 61.78 | |
| Neoleukin Therapeutics | 6.0 | $10M | 810k | 12.32 | |
| Karyopharm Therapeutics (KPTI) | 4.7 | $7.7M | 402k | 19.17 | |
| Ascendis Pharma A S (ASND) | 2.5 | $4.1M | 30k | 139.14 | |
| Achillion Pharmaceuticals | 2.3 | $3.8M | 625k | 6.03 | |
| Intersect Ent | 1.2 | $2.0M | 80k | 24.90 | |
| Kiniksa Pharmaceuticals | 1.1 | $1.8M | 165k | 11.06 | |
| Proteon Therapeutics | 0.1 | $140k | 342k | 0.41 |
